Ju-Ming Lu Selected Research

Ju-Ming Lu Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2003
3	Body Weight (Weight, Body) 01/2019 - 09/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2012 - 05/2012
2	Neoplasms (Cancer) 03/2018 - 02/2016
2	Cushing Syndrome 03/2018 - 01/2012
2	Insulinoma 12/2013 - 05/2012
2	Diabetes Mellitus 01/2013 - 08/2010
2	Adenoma (Adenomas) 01/2012 - 11/2011
2	Insulin Resistance 09/2010 - 01/2005
2	Glucose Intolerance 03/2009 - 09/2003
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Weight Gain 01/2019
1	Hyperplasia 03/2018
1	Acth-Independent Macronodular Adrenal Hyperplasia 03/2018
1	Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance) 08/2016
1	Autoimmune Diseases (Autoimmune Disease) 05/2016
1	Systemic Scleroderma (Systemic Sclerosis) 05/2016
1	Infections 05/2016
1	Hypertension (High Blood Pressure) 02/2016
1	Hypokalemia 02/2016
1	Wounds and Injuries (Trauma) 12/2013
1	Anemia 01/2013
1	Leukemia 05/2012
1	Hypesthesia (Numbness) 05/2012
1	Polyneuropathies (Polyneuropathy) 05/2012
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2012
1	Gigantism 11/2011
1	Stroke (Strokes) 11/2011
1	Acromegaly 11/2011
1	Autoimmune Hypophysitis 01/2011
1	Medullary Carcinoma 01/2011
1	Thyroid Neoplasms (Thyroid Cancer) 01/2011
1	Polycythemia Vera 11/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2010
1	Acute Coronary Syndrome 10/2010
1	Hyperglycemia 10/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2010
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2007
1	Hypercholesterolemia 05/2007
1	Obesity 04/2003

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2003
3	Insulin (Novolin)FDA Link 01/2019 - 09/2003
3	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2018 - 01/2011
3	NAD (NADH)IBA 10/2012 - 05/2012
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 10/2010
2	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 05/2007
2	Insulin ReceptorIBA 05/2016 - 09/2010
2	AlbuminsIBA 01/2013 - 06/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2013 - 06/2009
2	LipidsIBA 08/2010 - 09/2003
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019
1	lixisenatideIBA 12/2016
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2016
1	Glycated Serum AlbuminIBA 11/2016
1	Dihydrotachysterol (AT 10)IBA 11/2016
1	Hemoglobins (Hemoglobin)IBA 11/2016
1	Indicators and Reagents (Reagents)IBA 11/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2016
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 08/2016
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 08/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2016
1	B-insulinIBA 05/2016
1	AutoantibodiesIBA 05/2016
1	ReninIBA 02/2016
1	3-methyladenineIBA 12/2013
1	PalmitatesIBA 12/2013
1	ThapsigarginIBA 12/2013
1	VildagliptinIBA 08/2013
1	Metformin (Glucophage)FDA LinkGeneric 08/2013
1	Erythropoietin FDA Link 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Messenger RNA (mRNA)IBA 05/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2012
1	Growth Hormone (Somatotropin)IBA 11/2011
1	Hormones (Hormone)IBA 11/2011
1	Amyloid (Amyloid Fibrils)IBA 01/2011
1	GlucocorticoidsIBA 01/2011
1	Azathioprine (Imuran)FDA LinkGeneric 01/2011
1	InterferonsIBA 11/2010
1	NucleotidesIBA 09/2010
1	CholesterolIBA 05/2007
1	LDL Receptors (LDL Receptor)IBA 05/2007
1	HomocysteineIBA 01/2005
1	Pioglitazone (Actos)FDA Link 01/2005
1	Acarbose FDA LinkGeneric 09/2003
1	Nonesterified Fatty Acids (NEFA)IBA 04/2003
1	Testosterone (Sustanon)FDA Link 04/2003

Therapy/Procedure

5	Glycemic Control 01/2019 - 01/2013
5	Therapeutics 08/2013 - 11/2010
1	Injections 06/2013
1	Renal Dialysis (Hemodialysis) 01/2013
1	Laparoscopes (Laparoscope) 01/2012